Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook

SUV

  • You have access
    64Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours After Injection
    Mathias Loft, Esben A. Carlsen, Camilla B. Johnbeck, Helle H. Johannesen, Tina Binderup, Andreas Pfeifer, Jann Mortensen, Peter Oturai, Annika Loft, Anne K. Berthelsen, Seppo W. Langer, Ulrich Knigge and Andreas Kjaer
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 73-80; DOI: https://doi.org/10.2967/jnumed.120.244509
  • You have access
    Quantitative Test–Retest Measurement of 68Ga-PSMA-HBED-CC in Tumor and Normal Tissue
    Janet H. Pollard, Caleb Raman, Yousef Zakharia, Chad R. Tracy, Kenneth G. Nepple, Tim Ginader, Patrick Breheny and John J. Sunderland
    Journal of Nuclear Medicine August 1, 2020, 61 (8) 1145-1152; DOI: https://doi.org/10.2967/jnumed.119.236083
  • You have access
    Combined Visual and Semiquantitative Evaluation Improves Outcome Prediction by Early Midtreatment 18F-FDG PET in Diffuse Large B-Cell Lymphoma
    Tamás Györke, Robert Carr, Juliano J. Cerci, Claudio Meneghetti, Francisca Redondo, Monica Celli, Charity Gorospe, Chirayu U. Auewarakul, Linda Jorgov, Diana Paez and Stefano Fanti
    Journal of Nuclear Medicine July 1, 2020, 61 (7) 999-1005; DOI: https://doi.org/10.2967/jnumed.119.231621
  • You have access
    Tumor-to-Blood Ratio for Assessment of Somatostatin Receptor Density in Neuroendocrine Tumors Using 68Ga-DOTATOC and 68Ga-DOTATATE
    Ezgi Ilan, Irina Velikyan, Mattias Sandström, Anders Sundin and Mark Lubberink
    Journal of Nuclear Medicine February 1, 2020, 61 (2) 217-221; DOI: https://doi.org/10.2967/jnumed.119.228072
  • You have access
    Image Quality and Semiquantitative Measurements on the Biograph Vision PET/CT System: Initial Experiences and Comparison with the Biograph mCT
    Joyce van Sluis, Ronald Boellaard, Ananthi Somasundaram, Paul H. van Snick, Ronald J.H. Borra, Rudi A.J.O. Dierckx, Gilles N. Stormezand, Andor W.J.M. Glaudemans and Walter Noordzij
    Journal of Nuclear Medicine January 1, 2020, 61 (1) 129-135; DOI: https://doi.org/10.2967/jnumed.119.227801
  • You have access
    Test–Retest Reproducibility of 18F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local Network
    Brenda F. Kurland, Lanell M. Peterson, Andrew T. Shields, Jean H. Lee, Darrin W. Byrd, Alena Novakova-Jiresova, Mark Muzi, Jennifer M. Specht, David A. Mankoff, Hannah M. Linden and Paul E. Kinahan
    Journal of Nuclear Medicine May 1, 2019, 60 (5) 608-614; DOI: https://doi.org/10.2967/jnumed.118.209544
  • You have access
    Prognostic Value of Standardized Uptake Ratio in Patients with Trimodality Treatment of Locally Advanced Esophageal Carcinoma
    Rebecca Bütof, Frank Hofheinz, Klaus Zöphel, Julia Schmollack, Christina Jentsch, Sebastian Zschaeck, Jörg Kotzerke, Jörg van den Hoff and Michael Baumann
    Journal of Nuclear Medicine February 1, 2019, 60 (2) 192-198; DOI: https://doi.org/10.2967/jnumed.117.207670
  • You have access
    68Ga-PSMA-11 PET/CT in Newly Diagnosed Carcinoma of the Prostate: Correlation of Intraprostatic PSMA Uptake with Several Clinical Parameters
    Stefan A. Koerber, Maximilian T. Utzinger, Clemens Kratochwil, Claudia Kesch, Matthias F. Haefner, Sonja Katayama, Walter Mier, Andrei H. Iagaru, Klaus Herfarth, Uwe Haberkorn, Juergen Debus and Frederik L. Giesel
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 1943-1948; DOI: https://doi.org/10.2967/jnumed.117.190314
  • You have access
    Test–Retest Variability in Lesion SUV and Lesion SUR in 18F-FDG PET: An Analysis of Data from Two Prospective Multicenter Trials
    Frank Hofheinz, Ivayla Apostolova, Liane Oehme, Jörg Kotzerke and Jörg van den Hoff
    Journal of Nuclear Medicine November 1, 2017, 58 (11) 1770-1775; DOI: https://doi.org/10.2967/jnumed.117.190736
  • You have access
    Semiquantitative Parameters in PSMA-Targeted PET Imaging with 18F-DCFPyL: Variability in Normal-Organ Uptake
    Xin Li, Steven P. Rowe, Jeffrey P. Leal, Michael A. Gorin, Mohamad E. Allaf, Ashley E. Ross, Kenneth J. Pienta, Martin A. Lodge and Martin G. Pomper
    Journal of Nuclear Medicine June 1, 2017, 58 (6) 942-946; DOI: https://doi.org/10.2967/jnumed.116.179739

Pages

  • Next
  • 1
  • 2
  • 3
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire